1COUDRON PE, MOLAND ES, THOMSON KS. Occurrence and detection of AmpC beta - lactamases among Escherichia coli, klebsiella pneumoniae, and proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol, 2000, 38: 1791- 1796.
2LIVEMOR DM, WILLIAMS JD. β- lactamase: mode of action and mechanisms of bacterial resistance. In: Iorian W, ed. Antibtotics in Laboratory Medicine [ M ]. 4th ed. Baltimore: Williains & Wilkins, 1996. 502-578.
3SANDERS C.β- lactamase of gram negative bacteria:new challenge for new drugs [ J ]. Clin Infect Dis,1992, 14: 1089-1099.
4JONES RN. Importment and emerging β- lactamase mediated resistance in hospital - based pathogens: the Amp Cenzymes [ J ]. Diag Microbiol Infect Dis, 1998, 31:461 - 466.
5LANGAEE TY, GAGONO L, HULETSKY A. Inactivation of the AmpD gene in pseudomonas aeruginosa leads to moderate- basal - level and hyperinducible AmpC β-lactamase expression [J ]. Antimicrob Agents Chemother, 2000, 44: 583-589.
6EHRHARDT AF, SANDERS CL, ROMERO JR, et al.Sequencing and analysis of four new Enterobacter AmpD genes of Cirtrobacter freundi, and Enterobacter Cloacae[J]. Antimicrob Agents Chemother, 1996, dO: 1953-1956.
1Jones RN. Importment and emerging β-lactamase-mediated resistanee in hospital-based pathogens: the AmpC enzymes[J].Diagn Mierobiol Infect Dis, 1998, 31.-461-466.
2Langaee TY, Gagnon L, Huletsky A. Inactivation of the AmpD gene in Pseudomonas aeruginosa leads to moderatebasal-level and hyperinducible AmpCβ-lactamase expression[J]. Antimicrob Agents Chemother, 2000, 44:583-589.
3Korfmann G, Sanders CC, Moland ES. Altered phenotypes associated with AmpD mutation in E. cloacae[J]. Antimicrob Agents Chemother, 1991, 35:358-364.
4Chan WC, Li RC, Ling JM, et al. Markedly different rates and resistance profiles exhibited by seven commonly used and newer β-lactams on the selection of resistant variants of Enterobacter cloacae[J]. J Antimicrob Chemother, 1999, 44:55-60.
